The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
J Harding, M Sooriyakumaran, KJ Anstey, R Adams, B Balkau, T Briffa, TME Davis, WA Davis, A Dobson, GG Giles, J Grant, M Knuiman, M Luszcz, P Mitchell, JA Pasco, C Reid, D Simmons, L Simons, A Tonkin, M Woodward Show all
Diabetes & Metabolism | MASSON EDITEUR | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC)
this work is funded by a National Health and Medical Research Council (NHMRC grant APP1002663), Australian Government Department of Health. The work is supported, in part, by the Victorian Operational Infrastructure Scheme. JLH is supported by a Monash University Australian Postgraduate Award and a Baker IDI Bright Sparks scholarship, JES is supported by National Health and Medical Research Council Senior Research Fellowship (ID 526609), DJM is supported by a Victorian Cancer Agency Public Health Fellowship. Funding sources for individual studies can be found in baseline papers listed in the reference list.